|
 The Supervisory Board of Eppendorf SE has appointed Dr Christine Munz as the new CEO of the Eppendorf Group.
On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the company as planned.
“We are very pleased that we were able to win Dr. Munz for Eppendorf and the CEO position,” said Philipp von Loeper, the chairman of the Supervisory Board at Eppendorf SE. “On behalf of the entire Supervisory Board, I would also like to thank Dr. Plüster for his tremendous commitment to the company with which he has worked as CEO in the past few months. After serving more than 10 years on the Management Board of Eppendorf, he demonstrated once again his enormous dedication to the company. We are really pleased that he will remain at Eppendorf and assume another responsible position within the company.”
With Dr. Christine Munz Eppendorf will have a strong international experienced CEO, said von Loeper and added: “She is a proven and highly skilled manager with many years of experience in the life science industry. Working together with the global management team, Dr. Munz will continue to drive forward Eppendorf’s successful activities and expand them in a targeted manner.”
Eppendorf is a leading international company in the life science industry that develops, produces and markets devices, consumables and services used in laboratories around the world.
|